Original Article

Immunology and Cell Biology (1993) 71, 443–451; doi:10.1038/icb.1993.50

Vaccination against cestode parasites

Marshall W Lightowlers1 and Michael D Rickard2

  1. 1Molecular Parasitology Laboratory, University of Melbourne, Werribee, Australia
  2. 2Division of Animal Health, CSIRO, Parkville, Victoria, Australia

Correspondence: M. W. Lightowlers, University of Melbourne, Princes Highway, Werribee, Victoria 3030, Australia.

Accepted 17 May 1993.

Top

Abstract

Cestodes are tapeworm parasites. Infection in the intermediate host with larval (metacestode) parasites causes medically and economically important diseases known as hydatidosis and cysticercosis. Immunization against experimental infection with metacestode parasites has been highly successful, in marked contrast with the relative ineffectiveness of vaccines against infection with most parasitic organisms. High levels of immunity against a challenge infection with taeniid cestode eggs can be stimulated by immunization with extracts of the parasites, particularly with extracts of the oncosphere life-cycle stage. This led to the production of a recombinant antigen vaccine against infection in sheep with the parasite Taenia ovis, the first highly effective, non-living vaccine against a parasitic infection in animals or humans. This paper reviews immunity to the adult and metacestode life-cycle stages of cestode parasites, development and application of the T. ovis vaccine, and prospects for vaccines against other cestode infections.

Keywords:

cestode, parasite, tapeworm, vaccination.

Top

References

  1. Eckert, J, Gemmell, MA and Soulsby, EJL 1981. FAO/UNEP/WHO Guidelines for the Surveillance, Prevention and Control of Echinococcosis/Hydatidosis. World Health Organization, Geneva.
  2. Gemmell, MA, Matyas, Z, Pawlowski, Z and Soulsby, EJL 1983. FAO/UNEP/WHO Guidelines for Surveillance, Prevention and Control of Taeniasis/Cysticercosis. World Health Organization, Geneva.
  3. Matossian, RM, Rickard, MD and Smyth, JD. 1977. Hydatidosis: A global problem of increasing importance. Bull World Health Organ. 55: 499–507.
  4. Gemmell, MA, Lawson, JR and Roberts, MG. 1987. Towards global control of cystic and alveolar hydatid diseases. Parasitol. Today 3: 144–151.
  5. Johnson, KS, Harrison, GB, Lightowlers, MW et al. 1989. Vaccination against ovine cysticercosis using a defined recombinant antigen. Nature. 338: 585–587. | Article | PubMed | ISI | ChemPort |
  6. Williams, JF. 1979. Recent advances in the immunology of cestode infections. J Parasitol. 65: 337–349.
  7. Rickard, MD and Williams, JF. 1982. Hydatidosis/cysticercosis: Immune mechanisms and immunization against infection. Adv. Parasitol. 21: 229–296.
  8. Lightowlers, MW, Mitchell, GF and Rickard, MD. 1991. Cestodes. In Immunology and Molecular Biology of Parasitic Infections, K. S. Warren and N. Agabian (eds). Blackwell Scientific Publications, Cambridge, pp. 436–470.
  9. Kan, K. 1934. Immunological studies of Cysticercus fasciolaris. Keio Igaka 14: 663–687.
  10. Campbell, DH. 1936. Active immunization of albino rats with protein fractious from Taenia taeniaeformis and its larval form Cysticercus fasciolaris. Am. J. Hyg. 23: 104–113.
  11. Miller, HM. 1931. The production of artificial immunity in the albino rat to a metazoan parasite. J. Prev. Med. 5: 429–452.
  12. Miller, HM. 1931. Immunity in the white rat to super infestation with Cysticercus fasciolaris. Proc. Soc. Exp. Biol. 28: 467–468.
  13. Miller, HM and Gardiner, ML. 1932. Passive immunity to infection with a metazoan parasite, Cysticercus fasciolaris, in the albino rat. J Prev. Med. 6: 479–496.
  14. Miller, HM. 1932. Therapeutic effect of specific immune serums against a metazoan parasite (Cysticercus fasciolaris). Proc. Soc. Exp. Bid Med. 30: 82–83.
  15. Kerr, KB. 1935. Immunity against a cestode parasite — Cysticercus pisiformis. Am. J. Hyg. 22: 169–182.
  16. Campbell, DH. 1938. The specific absorbability of protective antibodies against Cysticercus crassicollis in rats and C. pisiformis in rabbits from infected and artificially immunized animals. J. Immunol. 35: 205–216.
  17. Mitchell, GF, Rajasekariah, GR and Rickard, MD. 1980. A mechanism to account for mouse strain variation in resistance to the larval cestode, Taenia taeniaeformis. Immunology 39: 481–489.
  18. Engelkirk, PG and Williams, JF. 1982. Taenia taeniaeformis (Cestoda) in the rat: Ultra-structure of the host–parasite interface on days 1 to 7 postinfection. J Parasitol. 68: 620–633.
  19. Engelkirk, PG and Williams, JF. 1983. Taenia taeniaeformis (Cestoda) in the rat: ultra-structure of the host–parasite interface on days 8 to 22 host infection. J. Parasitol. 69: 828–837.
  20. Lightowlers, MW, Gemmell, MA, Harrison, GLB, Heath, DD, Rickard, MD and Roberts, MG. 1992. Control of tissue parasites. II. Cestodes. In Animal Parasite Control Utilizing Biotechnology, W. K. Yong (ed.). CRC Press, Boca Raton, pp. 171–198.
  21. Gemmell, MA. 1964 Species specificity of the immunogenic complexes of the tapeworm hexacanth embryo. Nature 204: 705–707. | Article | PubMed | ISI | ChemPort |
  22. Gemmell, MA. 1964. Immunological responses of the mammalian host against tapeworm infections. I. Species specificity of hexacanth embryos in protecting sheep against Taenia hydatigena. J. Immunol. 7: 489–499.
  23. Gemmell, MA. 1965. Immunological responses of the mammalian host against tapeworm infections. III. Species specificity of hexacanth embryos in protecting sheep against Taenia ovis. J. Immunol. 8: 281–290.
  24. Gemmell, MA. 1966. Immunological responses of the mammalian host against tapeworm infections. IV. Species specificity of hexacanth embryos in protecting sheep against Echinococcus granulosus. Immunology. 11: 325–335.
  25. Gemmell, MA. 1967. Species specific and cross-protective functional antigens of the tapeworm embryo. Nature. 213: 500–501. | Article |
  26. Gemmell, MA. 1969. Immunological responses of the mammalian host against tapeworm infections. X. Immunization of sheep against Taenia hydatigena and T. ovis with chemically or physically treated embryos. Exp. Parasitol. 26: 58–66. | Article | PubMed | ChemPort |
  27. Gemmell, MA. 1970. Hydatidosis and cysticercosis. 3. Induced resistance to the larval phase. Aust. Vet. J. 46: 366–369.
  28. Rickard, MD and Bell, KJ. 1971. Immunity produced against Taenia ovis and T. taeniaeformis infection in lambs and rats following in vivo growth of their larvae in filtration membrane diffusion chambers. J Parasitol. 57: 571–575. | PubMed | ChemPort |
  29. Rickard, MD and Adolph, AJ. 1977. Vaccination of lambs against infection with Taenia ovis using antigens collected during short-term in vitro incubation of activated T. ovis oncospheres. Parasitology. 75: 183–188. | PubMed | ChemPort |
  30. Rajasekariah, GR, Mitchell, GF and Rickard, MD. 1980. Taenia taeniaeformis in mice: Protective immunization with oncospheres and their products. Int. J. Parasitol. 10: 155–160.
  31. Osborn, PJ, Heath, DD and Parmeter, SN. 1981. Immunisation of lambs against infection with Taenia ovis using an extract of Taenia ovis eggs. Res. Vet. Sci. 31: 90–92.
  32. Rajasekariah, GR, Rickard, MD, Mitchell, GF and Anders, RF. 1982. Immunization of mice against Taenia taeniaeformis using solubilized oncospheral antigens. Int. J. Parasitol. 12: 111–116.
  33. Lightowlers, MW, Mitchell, GF, Bowtell, DD, Anders, RF and Rickard, MD. 1984. Immunization against Taenia taeniaeformis in mice: Studies on the characterization of antigens from oncospheres. Int. J. Parasitol. 14: 321–333.
  34. Rickard, MD, Boddington, EB and McQuade, N. 1977. Vaccination of lambs against Taenia ovis infection using antigens collected during in vitro cultivation of larvae: Passive protection via colostrum from vaccinated ewes and the duration of immunity from a single vaccination. Res. Vet. Sci. 23: 368–371.
  35. Rickard, MD, Adolph, AJ and Arundel, JH. 1977. Vaccination of calves against Taenia saginata infection using antigens collected during in vitro cultivation of larvae: passive protection via colostrum from vaccinated cows and vaccination of calves protected by maternal antibody. Res. Vet. Sci. 23: 365–367.
  36. Rickard, MD and White, JB. 1976. Vaccination of lambs against infection with Taenia ovis. Aust. Vet. J. 52: 209–214.
  37. Rickard, MD, Brumley, JL and Anderson, GA. 1982. Field trial to evaluate the use of antigens from Taenia hydatigena oncospheres to prevent infection with Taenia saginata in cattle grazing on sewage–irrigated pasture. Res. Vet. Sci. 32: 189–193.
  38. Rickard, MD and Howell, MJ. 1987. Helminth vaccines. In In Vitro Methods for Parasite Cultivation, A. E. R. Taylor and J. R. Baker (eds). Academic Press, London, pp. 407–451.
  39. Bowtell, DD, Saint, RB, Rickard, MD and Mitchell, GF. 1984. Expression of Taenia taeniaeformis antigens in Escherichia coli. Mol. Biochem. Parasitol. 13: 173–185.
  40. Gemmell, MA, Lawson, JR, Roberts, MG, Kerin, BR and Mason, CJ. 1986. Population dynamics in echinococcosis and cysticercosis: comparison of the response of Echinococcus granulosus, Taenia hydatigena and T. ovis to control. Parasitology. 93: 357–369.
  41. Arundel, JH. 1972. A review of cysticercoses of sheep and cattle in Australia. Aust. Vet. J. 48: 140–155.
  42. Lightowlers, MW. 1990. Cestode infections in animals: Immunological diagnosis and vaccination. Rev. Sci. Tech. 9: 463–487.
  43. Gemmell, MA, Lawson, JR and Roberts, MG. 1986. Population dynamics in echino-coccosis and cysticercosis: Biological parameters of Echinococcus granulosus in dogs and sheep. Parasitology. 92: 599–620.
  44. Rickard, MD. 1983. Immunity. In The Biology of the Eucestoda, C. Arme and P. Pappas (eds). Academic Press, London, pp. 539–579.
  45. Yong, WK. 1992. Animal Parasite Control Utilizing Biotechnology, CRC Press, Boca Raton.

Extra navigation

.

naturejobs

ADVERTISEMENT